Therefore, the expression of MAGE-A6 and MAGE-A11 phenotypes were classified into 4 subgroups; among 158 BC cases of cytoplasmic expression, 23 (14.6%) showed MAGE-A6Low (l)/MAGE-A11l phenotype,38 (24.1%) MAGE-A6high (h)/MAGE-A11l, 22 (13.9%) MAGE-A6 l/ MAGE-A11 h and 75(47.5%) MAGE-A6h/MAGE-A11h. This evidence concerns the gene MAGEA11 and breast cancer.